It belongs to the class called opiate antagonists and is used, together with counseling and social support, to help people who have stopped drinking alcohol or using opioids reduce cravings and control dependence. At a lower dose it is also one of the two ingredients of Contrave, a weight-management tablet, where it is paired with the antidepressant bupropion.1,2
How it works
MedlinePlus describes naltrexone as working by decreasing the craving for alcohol and by blocking the effects of opioids. Because of that block, opioid medicines and opioid street drugs do not have their usual effect while it is being taken.1 It is not an opioid itself and is not a GLP-1 medicine.
For weight, the Contrave label treats naltrexone and bupropion as one product and reports the results of the pair, not of naltrexone alone.2
How it is used on its own
On its own, naltrexone comes as a tablet. At home it is taken once a day, with or without food, at about the same time each day. In a clinic or treatment center the schedule can be once a day, every other day, every third day, or every day except Sunday. MedlinePlus stresses that it works best as part of an addiction treatment program.1
Before the first dose, doctors make sure there has been no opioid use in the last 7 to 10 days. That includes opioid medicines for pain, cough or diarrhea, methadone and buprenorphine, as well as street drugs such as heroin. A doctor may order tests to check, and will not start naltrexone after recent opioid use. Opioids are also to be avoided during treatment.1
Naltrexone in Contrave
Each Contrave tablet holds 8 mg of naltrexone hydrochloride and 90 mg of bupropion hydrochloride. At the full dose, two tablets twice a day from week 4, the daily total is 32 mg of naltrexone. Over 56 weeks in the COR-I trial, weight fell by 5.4% on Contrave against 1.3% on placebo.2
The opioid block carries over. The Contrave label rules it out for people on long-term opioids such as methadone or buprenorphine or in acute opioid withdrawal. It warns that opioid painkillers, cough remedies and antidiarrheals may not work fully. It also warns that trying to overcome the block with large opioid doses can cause a fatal overdose.2 Anyone facing surgery or a procedure that may need opioid pain relief should tell the care team about it.
Side effects
MedlinePlus lists the common side effects of naltrexone tablets as nausea, vomiting, stomach pain or cramping, diarrhea, constipation, loss of appetite, headache, dizziness, anxiety, nervousness, irritability, trouble sleeping, changes in energy, drowsiness, muscle or joint pain and rash.1
Some side effects are serious enough to call a doctor at once. MedlinePlus names excessive tiredness, unusual bleeding or bruising, and pain in the upper right part of the stomach. It also names light-colored stools, dark urine, yellowing of the skin or eyes, confusion, hallucinations, blurred vision, severe vomiting or diarrhea, and thoughts of suicide.1
Naltrexone and GLP-1 medicines
The two come up together because both are discussed for alcohol use. Naltrexone is an established treatment for alcohol dependence.1 GLP-1 medicines are not approved for it. Still, a Swedish cohort found fewer hospital stays for alcohol use during semaglutide and liraglutide use, and a small randomized trial found that semaglutide reduced craving and the amount drunk per drinking day.3,4 Our page on alcohol on a GLP-1 sets out what those studies did and did not show.
Nausea is the side effect the two share most clearly: it is on the MedlinePlus list for naltrexone and is the most common reaction on the GLP-1 labels.1 Our page on nausea on a GLP-1 covers what helps.
Sources
- MedlinePlus. Naltrexone. U.S. National Library of Medicine; last revised September 15, 2026, read November 20, 2026. medlineplus.gov
- CONTRAVE (naltrexone HCl and bupropion HCl) extended-release tablets prescribing information. DailyMed, U.S. National Library of Medicine, version published November 17, 2025; sections 1, 2, 4, 5, 7.2 and 14. dailymed.nlm.nih.gov
- L盲hteenvuo M, Tiihonen J, Solismaa A, et al. Repurposing semaglutide and liraglutide for alcohol use disorder. JAMA Psychiatry 2025;82:94-98. doi:10.1001/jamapsychiatry.2024.3599
- Hendershot CS, Bremmer MP, et al. Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry 2025;82:395-405. doi:10.1001/jamapsychiatry.2024.4789
Related analyses
Alcohol on a GLP-1: what the labels say, what counts as a drink, and what five studies found
Nausea on a GLP-1: how common, how long, when it peaks and what helps
GLP-1 cost without insurance: every manufacturer self-pay price, dose by dose
Ozempic side effects: how common each one is by dose, and when they ease
Log your medicines, doses and symptoms together in one place.
Open Dose Insider